Skip to main content

Evolvable platform for programmable nanoparticle-based cancer therapies

Objective

EVO-NANO aims to create an integrated cross-disciplinary platform for the artificial evolution and assessment of nanoparticle-based drug delivery systems. Nanoparticles (NP) are increasingly being studied in cancer research for their ability to improve diagnosis accuracy and/or deliver tailored treatments directly to tumours. However, their effective biodistribution is still a major limitation. The challenge is to discover how to program collective behaviour of the trillions of NP interacting in a complex tumour environment. Finding effective NP designs that give rise to desired outcome will require a new class of evolutionary algorithms that can simultaneously 1) generate novel NP-based anti-cancer strategies, 2) search over a large space of solutions, and 3) adapt to a wide variety of scenarios. Our novel evolutionary approach will be integrated with molecular dynamics simulations, PhysiCell (http://physicell.mathcancer.org) and STEPS simulators that reproduces realistic NP motion and interactions within the tumour environment and with other NP. The most promising NP designs will then be synthesized and tested in vivo and in vitro on breast and colon cancer stem cells using mouse cancer xenografts and microfluidic testbeds featuring cancer microenvironments. To promote translation of the platform from early stage research into a commercialized product for patients, we will work with industrial partner ProChimia Surfaces, organize ‘Industry Open Days’ for potential investors and develop a translation strategy.
EVO-NANO is a multidisciplinary project that will create an entirely novel NP design platform for new cancer treatments, capable of autonomously evolving both innovative and adaptive solutions. The proposed platform has the potential to be at the forefront of cancer nanomedicine by enabling much faster development and assessment of new cancer treatments, than is done today. The project will generate concrete tools for the predictive design of nanomedicines that could be applied in other clinical fields.

Call for proposal

H2020-FETOPEN-2016-2017

See other projects for this call

Sub call

H2020-FETOPEN-1-2016-2017

Coordinator

UNIVERZITET U NOVOM SADU, POLJOPRIVREDNI FAKULTET NOVI SAD
Net EU contribution
€ 284 843,75
Address
Trg Dositeja Obradovica 8
21000 Novi Sad
Serbia

See on map

Region
Србија - север Регион Војводине Јужнобачка област
Activity type
Higher or Secondary Education Establishments
Other funding
€ 284 843,75

Participants (6)

UNIVERSITY OF BRISTOL
United Kingdom
Net EU contribution
€ 407 056,25
Address
Beacon House Queens Road
BS8 1QU Bristol

See on map

Region
South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Bristol, City of
Activity type
Higher or Secondary Education Establishments
Other funding
€ 407 056,25
ABO AKADEMI
Finland
Net EU contribution
€ 268 861,25
Address
Domkyrkotorget 3
20500 Abo

See on map

Region
Manner-Suomi Etelä-Suomi Varsinais-Suomi
Activity type
Higher or Secondary Education Establishments
Other funding
€ 268 861,25
UNIVERSITY OF THE WEST OF ENGLAND, BRISTOL
United Kingdom
Net EU contribution
€ 445 925,00
Address
Frenchay Campus, Coldharbour Lane
BS16 1QY Bristol

See on map

Region
South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Bath and North East Somerset, North Somerset and South Gloucestershire
Activity type
Higher or Secondary Education Establishments
Other funding
€ 445 925,00
FUNDACION IMDEA NANOCIENCIA
Spain
Net EU contribution
€ 498 750,00
Address
Calle Faraday 9 Ciudad Universitaria De Cantoblanco
28049 Madrid

See on map

Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Other funding
€ 498 750,00
PROCHIMIA SURFACES SP. Z O.O.
Poland
Net EU contribution
€ 514 375,00
Address
Zacisze 2
81823 Sopot

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Makroregion północny Pomorskie Trójmiejski
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 514 375,00
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
Spain
Net EU contribution
€ 568 847,50
Address
Passeig Vall D Hebron 119-129 Edificio De Recerca
08035 Barcelona

See on map

Region
Este Cataluña Barcelona
Activity type
Research Organisations
Other funding
€ 568 847,50